I too have investigated the identity of Watson bas
Post# of 30028
Posted On: 08/24/2014 2:41:20 AM
Re: seebisquick #4674
I too have investigated the identity of Watson based on his comments regarding the April 2013 conference call. Since Watson claimed to have asked a question (singular), there are several callers who could be eliminated (assuming Watson wasn't intentionally trying to mislead with that claim).
Jason Napadano of Zacks asked the first 5 questions.
Matthew Margolis of OneMedPlace asked the next 2 questions.
Lewis Sogge asked the next question about the Myriad Genetics case in the Supreme Court. Lewis is a young college student who did a great deal of the early DD as an AMBS investor. He posted as lewsogge on IHUB and often used the phrase, "Know what you own." He was spooked by the Myriad Supreme Court case and how it might affect AMBS, and he exited the stock shortly after the conference call. There's no way this guy could be Watson.
John Leese asked the next 2 questions, which related to operating costs/cash requirements and reverse split. Doesn't seem likely this is Watson given the "retail shareholder" nature of the call. I believe Watson would have asked a different type of question given his apparent extensive knowledge of the biotech arena.
Gina Thompson asked the next 2 questions related to pharma partnerships and structure of the holding company. We generally rule out this caller because they are female and we're assuming Watson is male. Plus, she asked multiple questions.
The last caller, Scot Lee of Burlington Coat Factory, asked about regulatory approval options regarding FDA (USA) and EMEA (Europe). This seems to be the most likely Watson candidate because the content of many of his Yahoo board messages discuss regulatory options both with FDA and EMEA. But I get the impression from his posts that Watson lives abroad and perhaps is not even a U.S. citizen. So that sheds some doubt on this guy being Watson.
So, after all this amateur detective work, I'm still left scratching my head over who Watson might be. Hopefully one day we'll find out, as Watson has stated his identity will be revealed at a point where it is safe to do so.
Jason Napadano of Zacks asked the first 5 questions.
Matthew Margolis of OneMedPlace asked the next 2 questions.
Lewis Sogge asked the next question about the Myriad Genetics case in the Supreme Court. Lewis is a young college student who did a great deal of the early DD as an AMBS investor. He posted as lewsogge on IHUB and often used the phrase, "Know what you own." He was spooked by the Myriad Supreme Court case and how it might affect AMBS, and he exited the stock shortly after the conference call. There's no way this guy could be Watson.
John Leese asked the next 2 questions, which related to operating costs/cash requirements and reverse split. Doesn't seem likely this is Watson given the "retail shareholder" nature of the call. I believe Watson would have asked a different type of question given his apparent extensive knowledge of the biotech arena.
Gina Thompson asked the next 2 questions related to pharma partnerships and structure of the holding company. We generally rule out this caller because they are female and we're assuming Watson is male. Plus, she asked multiple questions.
The last caller, Scot Lee of Burlington Coat Factory, asked about regulatory approval options regarding FDA (USA) and EMEA (Europe). This seems to be the most likely Watson candidate because the content of many of his Yahoo board messages discuss regulatory options both with FDA and EMEA. But I get the impression from his posts that Watson lives abroad and perhaps is not even a U.S. citizen. So that sheds some doubt on this guy being Watson.
So, after all this amateur detective work, I'm still left scratching my head over who Watson might be. Hopefully one day we'll find out, as Watson has stated his identity will be revealed at a point where it is safe to do so.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼